Condition
the Severity and Duration of Intraoperative Hypotension
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07405892Not ApplicableNot Yet RecruitingPrimary
Applying HPI in Oral Cancer Surgery
NCT06258356Not ApplicableNot Yet RecruitingPrimary
Remimazolam in High Risk ERCP Patients
NCT05297318Not ApplicableCompletedPrimary
HPI in Older Patients Undergoing Major Gastrointestinal Surgery
Showing all 3 trials